Carson Wealth (CWM LLC)’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
VPM
VCM
S
Carson Wealth (CWM LLC)'s NVAX Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Novavax (NVAX) stake by 113% in Q1 2026, buying an estimated $8.79K and bringing the position to 1,829 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4593.
Carson Wealth (CWM LLC) first reported a position in NVAX in Q1 2019 and has held it in 28 quarters since. The position peaked at $197K in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Carson Wealth (CWM LLC) held 1,829 shares of Novavax worth $14.9K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 970 Novavax shares in Q1 2026, an estimated $8.79K.
- Novavax made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4593 holding.
- Carson Wealth (CWM LLC) first reported a position in Novavax in Q1 2019 and has held it in 28 quarters since.
- Carson Wealth (CWM LLC)'s Novavax position peaked at $197K in Q4 2021.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.